People

We are scientists, educators, project managers, industry experts, and business and nonprofit leaders working together to more effectively advance academic discoveries from the lab to the clinic.

An orange curve, coming from the bottom and curving to the top right.

Our Team

Stephen Kargotich PhD, MBA, LLB

Stephen Kargotich PhD, MBA, LLB

Executive Director

Daria Mochly-Rosen, PhD

Daria Mochly-Rosen, PhD

Chief Science and Education Advisor

Kevin Grimes, MD, MBA

Kevin Grimes, MD, MBA

Chief Clinical and Education Advisor

Opher Kornfeld, PhD

Opher Kornfeld, PhD

Director of Translational Research and Development

Marisol Urbano

Marisol Urbano

Director of Programs

Charlene Chabata, PhD

Charlene Chabata, PhD

Project Manager

Adriana Garcia, PhD

Adriana Garcia, PhD

Education Manager

Eduardo González-Maldonado

Eduardo González-Maldonado, PhD

Project Manager

Monet Jimenez, PhD

Monet Jimenez, PhD

Learning Experience Designer

Robert Lum, PhD

Robert Lum, PhD

CRO and Vendor Manager

Inbal Maayan, PhD

Inbal Maayan, PhD

Learning Experience Designer

Shadi Nasiri

Shadi Nasiri

Event Manager

Photo of Ralitsa Petrova, PhD

Ralitsa Petrova, PhD

Project Manager

Ravi Ponnusamy, PhD

Ravi Ponnusamy, PhD

Senior Project Manager

Jeyanthi Ramasubbu, PhD

Jeyanthi Ramasubbu, PhD

Senior Project Manager

Susan Thomas

Susan Thomas

Communications Director

Industry Advisors

Our 50+ industry expert advisors have experience in every aspect of the drug discovery and development process and long track records of success advancing academic discoveries from lab to clinic. Academic researchers in our programs benefit from cohort-wide project and progress meetings attended by panels of advisors at the same time as well as one-on-one or small group mentoring in areas of need.

  • Blue dot icon

    Clinical Operations

  • Dot icon

    Venture Capital

  • Blue dot icon

    Diagnostics & Biomarkers

  • Blue dot icon

    Pharmacology

  • Blue dot icon

    Legal & Licensing

  • Blue dot icon

    Medical Affairs

  • Blue dot icon

    Pharma Business Development

  • Blue dot icon

    Medicinal Chemistry

  • Blue dot icon

    Clinical Trial Design

  • Blue dot icon

    Regulatory

  • Blue dot icon

    Formulation

  • Blue dot icon

    Entrepreneurship

  • Blue dot icon

    Antibody Engineering

Call for Proposals

SPARK NS 2025 Parkinson’s Disease Translational Research Program

SPARK NS is no longer accepting applications for this program. Finalists will present September 13-15, 2024. Selected projects will be notified October 4, 2024. We will release a Call for Proposals for our 2026 program in April 2025.

Sign up for updates